{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:42:30Z","timestamp":1792460550470,"version":"4.5.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR061106"],"award-info":[{"award-number":["R01 AR061106"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002632","name":"Hallym University","doi-asserted-by":"publisher","award":["H20180060"],"award-info":[{"award-number":["H20180060"]}],"id":[{"id":"10.13039\/501100002632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autism, a childhood behavioral disorder, belongs to a large suite of diseases, collectively referred to as autism spectrum disorders (ASD). Though multifactorial in etiology, approximately 10% of ASD are associated with atopic dermatitis (AD). Moreover, ASD prevalence increases further as AD severity worsens, though these disorders share no common causative mutations. We assessed here the link between these two disorders in the standard, valproic acid mouse model of ASD. In prior studies, there was no evidence of skin involvement, but we hypothesized that cutaneous involvement could be detected in experiments conducted in BALB\/c mice. BALB\/c is an albino, laboratory-bred strain of the house mouse and is among the most widely used inbred strains used in animal experimentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed our studies in valproic acid (VPA)-treated BALB\/c hairless mice, a standard mouse model of ASD. Mid-trimester pregnant mice received a single intraperitoneal injection of either valproic acid sodium salt dissolved in saline or saline alone on embryonic day 12.5 and were housed individually until postnatal day 21. Only the brain and epidermis appeared to be affected, while other tissues remain unchanged. At various postnatal time points, brain, skin and blood samples were obtained for histology and for quantitation of tissue sphingolipid content and cytokine levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      AD-like changes in ceramide content occurred by day one postpartum in both VPA-treated mouse skin and brain. The temporal co-emergence of AD and ASD, and the AD phenotype-dependent increase in ASD prevalence correlated with early appearance of cytokine markers (i.e., interleukin [IL]-4, 5, and 13), as well as mast cells in skin and brain. The high levels of interferon (IFN)\u03b3 not only in skin, but also in brain likely account for a significant decline in esterified very-long-chain\n                      <jats:italic>N<\/jats:italic>\n                      -acyl fatty acids in brain ceramides, again mimicking known IFN\u03b3-induced changes in AD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Baseline involvement of both AD and ASD could reflect concurrent neuro- and epidermal toxicity, possibly because both epidermis and neural tissues originate from the embryonic neuroectoderm. These studies illuminate the shared susceptibility of the brain and epidermis to a known neurotoxin, suggesting that the atopic diathesis could be extended to include ASD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12868-021-00645-0","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T04:02:45Z","timestamp":1624334565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Phenotypic overlap between atopic dermatitis and autism"],"prefix":"10.1186","volume":"22","author":[{"given":"Kyong-Oh","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra A.","family":"Crumrine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yerin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Abuabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaehyeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan S.","family":"Wakefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sekyoo","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong Deog","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7989-4032","authenticated-orcid":false,"given":"Peter M.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"645_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.0007","author":"K Abuabara","year":"2021","unstructured":"Abuabara K. Atopic dermatitis and academic achievement-more to learn. JAMA Dermatol. 2021. https:\/\/doi.org\/10.1001\/jamadermatol.2021.0007.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"645_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1023\/A:1016374617369","volume":"32","author":"KA Pelphrey","year":"2002","unstructured":"Pelphrey KA, Sasson NJ, Reznick JS, Paul G, Goldman BD, Piven J. Visual scanning of faces in autism. J Autism Dev Disord. 2002;32(4):249\u201361.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"645_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/archgenpsychiatry.2010.113","volume":"68","author":"K Pierce","year":"2011","unstructured":"Pierce K, Conant D, Hazin R, Stoner R, Desmond J. Preference for geometric patterns early in life as a risk factor for autism. Arch Gen Psychiatry. 2011;68(1):101\u20139.","journal-title":"Arch Gen Psychiatry"},{"issue":"7526","key":"645_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nature13772","volume":"515","author":"S De Rubeis","year":"2014","unstructured":"De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, Kou Y, Liu L, Fromer M, Walker S, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014;515(7526):209\u201315.","journal-title":"Nature"},{"issue":"3","key":"645_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12035-011-8198-9","volume":"44","author":"C Jacob","year":"2011","unstructured":"Jacob C, Lebrun-Julien F, Suter U. How histone deacetylases control myelination. Mol Neurobiol. 2011;44(3):303\u201312.","journal-title":"Mol Neurobiol"},{"key":"645_CR6","doi-asserted-by":"publisher","first-page":"712758","DOI":"10.1155\/2013\/712758","volume":"2013","author":"T Chomiak","year":"2013","unstructured":"Chomiak T, Turner N, Hu B. What we have learned about autism spectrum disorder from valproic acid. Pathol Res Int. 2013;2013:712758.","journal-title":"Pathol Res Int"},{"key":"645_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","volume":"36","author":"FI Roullet","year":"2013","unstructured":"Roullet FI, Lai JK, Foster JA. In utero exposure to valproic acid and autism\u2014a current review of clinical and animal studies. Neurotoxicol Teratol. 2013;36:47\u201356.","journal-title":"Neurotoxicol Teratol"},{"key":"645_CR8","doi-asserted-by":"publisher","first-page":"35322","DOI":"10.1038\/srep35322","volume":"6","author":"U Golla","year":"2016","unstructured":"Golla U, Joseph D, Tomar RS. Combined transcriptomics and chemical-genetics reveal molecular mode of action of valproic acid, an anticancer molecule using budding yeast model. Sci Rep. 2016;6:35322.","journal-title":"Sci Rep"},{"issue":"3","key":"645_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/JLB.3AB0320-547RR","volume":"108","author":"GM Rodriguez-Lopez","year":"2020","unstructured":"Rodriguez-Lopez GM, Soria-Castro R, Campillo-Navarro M, Perez-Tapia SM, Flores-Borja F, Wong-Baeza I, Munoz-Cruz S, Lopez-Santiago R, Estrada-Parra S, Estrada-Garcia I, et al. The histone deacetylase inhibitor valproic acid attenuates phospholipase Cgamma2 and IgE-mediated mast cell activation. J Leukoc Biol. 2020;108(3):859\u201366.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"645_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2165\/00023210-199402020-00007","volume":"2","author":"J Balfour","year":"1994","unstructured":"Balfour J, Bryson H. Valproic acid: a review of its pharmacology and therapeutic potential in indications other than epilepsy. CNS Drugs. 1994;2(2):144\u201373.","journal-title":"CNS Drugs"},{"issue":"5","key":"645_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1517\/17425250902911455","volume":"5","author":"PM Haddad","year":"2009","unstructured":"Haddad PM, Das A, Ashfaq M, Wieck A. A review of valproate in psychiatric practice. Expert Opin Drug Metab Toxicol. 2009;5(5):539\u201351.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"7","key":"645_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1136\/jmg.37.7.489","volume":"37","author":"SJ Moore","year":"2000","unstructured":"Moore SJ, Turnpenny P, Quinn A, Glover S, Lloyd DJ, Montgomery T, Dean JC. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet. 2000;37(7):489\u201397.","journal-title":"J Med Genet"},{"issue":"4","key":"645_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/jmg.39.4.251","volume":"39","author":"JC Dean","year":"2002","unstructured":"Dean JC, Hailey H, Moore SJ, Lloyd DJ, Turnpenny PD, Little J. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet. 2002;39(4):251\u20139.","journal-title":"J Med Genet"},{"issue":"10","key":"645_CR14","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1007\/s11064-016-1969-y","volume":"41","author":"T Kawanai","year":"2016","unstructured":"Kawanai T, Ago Y, Watanabe R, Inoue A, Taruta A, Onaka Y, Hasebe S, Hashimoto H, Matsuda T, Takuma K. Prenatal exposure to histone deacetylase inhibitors affects gene expression of autism-related molecules and delays neuronal maturation. Neurochem Res. 2016;41(10):2574\u201384.","journal-title":"Neurochem Res"},{"issue":"3","key":"645_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ajhg.2019.01.010","volume":"104","author":"B Cogne","year":"2019","unstructured":"Cogne B, Ehresmann S, Beauregard-Lacroix E, Rousseau J, Besnard T, Garcia T, Petrovski S, Avni S, McWalter K, Blackburn PR, et al. Missense variants in the histone acetyltransferase complex component gene TRRAP cause autism and syndromic intellectual disability. Am J Hum Genet. 2019;104(3):530\u201341.","journal-title":"Am J Hum Genet"},{"issue":"Pt A","key":"645_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.brainres.2015.10.011","volume":"1641","author":"SD Ackerman","year":"2016","unstructured":"Ackerman SD, Monk KR. The scales and tales of myelination: using zebrafish and mouse to study myelinating glia. Brain Res. 2016;1641(Pt A):79\u201391.","journal-title":"Brain Res"},{"issue":"7673","key":"645_CR17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature23909","volume":"549","author":"Y Shin Yim","year":"2017","unstructured":"Shin Yim Y, Park A, Berrios J, Lafourcade M, Pascual LM, Soares N, Yeon Kim J, Kim S, Kim H, Waisman A, et al. Reversing behavioural abnormalities in mice exposed to maternal inflammation. Nature. 2017;549(7673):482\u20137.","journal-title":"Nature"},{"issue":"5","key":"645_CR18","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.neuron.2014.07.040","volume":"83","author":"G Tang","year":"2014","unstructured":"Tang G, Gudsnuk K, Kuo SH, Cotrina ML, Rosoklija G, Sosunov A, Sonders MS, Kanter E, Castagna C, Yamamoto A, et al. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron. 2014;83(5):1131\u201343.","journal-title":"Neuron"},{"issue":"2","key":"645_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1242\/dev.046441","volume":"138","author":"DA Gibson","year":"2011","unstructured":"Gibson DA, Ma L. Developmental regulation of axon branching in the vertebrate nervous system. Development. 2011;138(2):183\u201395.","journal-title":"Development"},{"issue":"1","key":"645_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrn3650","volume":"15","author":"K Kalil","year":"2014","unstructured":"Kalil K, Dent EW. Branch management: mechanisms of axon branching in the developing vertebrate CNS. Nat Rev Neurosci. 2014;15(1):7\u201318.","journal-title":"Nat Rev Neurosci"},{"issue":"44","key":"645_CR21","doi-asserted-by":"publisher","first-page":"14595","DOI":"10.1523\/JNEUROSCI.2257-10.2010","volume":"30","author":"B Zikopoulos","year":"2010","unstructured":"Zikopoulos B, Barbas H. Changes in prefrontal axons may disrupt the network in autism. J Neurosci. 2010;30(44):14595\u2013609.","journal-title":"J Neurosci"},{"issue":"1","key":"645_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3233\/BPL-160033","volume":"2","author":"AL MacKay","year":"2016","unstructured":"MacKay AL, Laule C. Magnetic resonance of myelin water: an in vivo marker for myelin. Brain Plast. 2016;2(1):71\u201391.","journal-title":"Brain Plast"},{"issue":"6276","key":"645_CR23","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1126\/science.aaf2850","volume":"351","author":"ML Estes","year":"2016","unstructured":"Estes ML, McAllister AK. Immunology. Maternal TH17 cells take a toll on baby\u2019s brain. Science. 2016;351(6276):919\u201320.","journal-title":"Science"},{"issue":"6301","key":"645_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1126\/science.aag3194","volume":"353","author":"ML Estes","year":"2016","unstructured":"Estes ML, McAllister AK. Maternal immune activation: implications for neuropsychiatric disorders. Science. 2016;353(6301):772\u20137.","journal-title":"Science"},{"issue":"Pt A","key":"645_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.expneurol.2017.04.010","volume":"299","author":"H Wong","year":"2018","unstructured":"Wong H, Hoeffer C. Maternal IL-17A in autism. Exp Neurol. 2018;299(Pt A):228\u201340.","journal-title":"Exp Neurol"},{"issue":"5","key":"645_CR26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00401-015-1402-7","volume":"129","author":"A Waisman","year":"2015","unstructured":"Waisman A, Hauptmann J, Regen T. The role of IL-17 in CNS diseases. Acta Neuropathol. 2015;129(5):625\u201337.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"645_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.it.2011.02.007","volume":"32","author":"J Zepp","year":"2011","unstructured":"Zepp J, Wu L, Li X. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol. 2011;32(5):232\u20139.","journal-title":"Trends Immunol"},{"issue":"4","key":"645_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1177\/039463200902200401","volume":"22","author":"TC Theoharides","year":"2009","unstructured":"Theoharides TC. Autism spectrum disorders and mastocytosis. Int J Immunopathol Pharmacol. 2009;22(4):859\u201365.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"645_CR29","doi-asserted-by":"publisher","first-page":"e844","DOI":"10.1038\/tp.2016.77","volume":"6","author":"TC Theoharides","year":"2016","unstructured":"Theoharides TC, Tsilioni I, Patel AB, Doyle R. Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders. Transl Psychiatry. 2016;6(6):e844.","journal-title":"Transl Psychiatry"},{"issue":"2","key":"645_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s40257-016-0181-9","volume":"17","author":"L Billeci","year":"2016","unstructured":"Billeci L, Tonacci A, Tartarisco G, Ruta L, Pioggia G, Gangemi S. Reply to Fluegge: association between atopic dermatitis and autism spectrum disorders: a systematic review. Am J Clin Dermatol. 2016;17(2):189\u201390.","journal-title":"Am J Clin Dermatol"},{"issue":"39","key":"645_CR31","doi-asserted-by":"publisher","first-page":"e5005","DOI":"10.1097\/MD.0000000000005005","volume":"95","author":"CY Lee","year":"2016","unstructured":"Lee CY, Chen MH, Jeng MJ, Hsu JW, Tsai SJ, Bai YM, Hung GY, Yen HJ, Chen TJ, Su TP. Longitudinal association between early atopic dermatitis and subsequent attention-deficit or autistic disorder. Medicine. 2016;95(39):e5005.","journal-title":"Medicine"},{"key":"645_CR32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jpeds.2015.12.063","volume":"171","author":"TC Liao","year":"2016","unstructured":"Liao TC, Lien YT, Wang S, Huang SL, Chen CY. Comorbidity of atopic disorders with autism spectrum disorder and attention deficit\/hyperactivity disorder. J Pediatr. 2016;171:248\u201355.","journal-title":"J Pediatr"},{"issue":"4","key":"645_CR33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jpsychores.2014.06.006","volume":"77","author":"MH Chen","year":"2014","unstructured":"Chen MH, Su TP, Chen YS, Hsu JW, Huang KL, Chang WH, Chen TJ, Pan TL, Bai YM. Is atopy in early childhood a risk factor for ADHD and ASD? A longitudinal study. J Psychosom Res. 2014;77(4):316\u201321.","journal-title":"J Psychosom Res"},{"issue":"8","key":"645_CR34","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/archpedi.160.8.825","volume":"160","author":"JG Gurney","year":"2006","unstructured":"Gurney JG, McPheeters ML, Davis MM. Parental report of health conditions and health care use among children with and without autism: National Survey of Children\u2019s Health. Arch Pediatr Adolesc Med. 2006;160(8):825\u201330.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"645_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1742-2094-5-52","volume":"5","author":"H Jyonouchi","year":"2008","unstructured":"Jyonouchi H, Geng L, Cushing-Ruby A, Quraishi H. Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J Neuroinflammation. 2008;5:52.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"645_CR36","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ejpn.2007.12.008","volume":"12","author":"B Bakkaloglu","year":"2008","unstructured":"Bakkaloglu B, Anlar B, Anlar FY, Oktem F, Pehlivanturk B, Unal F, Ozbesler C, Gokler B. Atopic features in early childhood autism. Eur J Paediatr Neurol. 2008;12(6):476\u20139.","journal-title":"Eur J Paediatr Neurol"},{"key":"645_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.rasd.2012.08.008","volume":"7","author":"MH Chen","year":"2013","unstructured":"Chen MH, Su TP, Chen Y, Hsu JW, Huang KL, Chang W, Chen TC, Bai YM. Comorbidity of allergic and autoimmune diseases in patients with autism spectrum disorder: a nationwide population-based study. Res Autism Spectr Disord. 2013;7:205\u201312.","journal-title":"Res Autism Spectr Disord"},{"issue":"2","key":"645_CR38","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jaci.2012.10.041","volume":"131","author":"P Yaghmaie","year":"2013","unstructured":"Yaghmaie P, Koudelka CW, Simpson EL. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol. 2013;131(2):428\u201333.","journal-title":"J Allergy Clin Immunol"},{"key":"645_CR39","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.0008","author":"J Wan","year":"2021","unstructured":"Wan J, Mitra N, Hooper SR, Hoffstad OJ, Margolis DJ. Association of atopic dermatitis severity with learning disability in children. JAMA Dermatol. 2021. https:\/\/doi.org\/10.1001\/jamadermatol.2021.0008.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"645_CR40","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jaci.2014.05.048","volume":"134","author":"PM Elias","year":"2014","unstructured":"Elias PM, Wakefield JS. Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol. 2014;134(4):781\u201391.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"645_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1600-0625.2006.00529.x","volume":"16","author":"M Denda","year":"2007","unstructured":"Denda M, Nakatani M, Ikeyama K, Tsutsumi M, Denda S. Epidermal keratinocytes as the forefront of the sensory system. Exp Dermatol. 2007;16(3):157\u201361.","journal-title":"Exp Dermatol"},{"issue":"7","key":"645_CR42","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/sj.jid.5701239","volume":"128","author":"J Nikolovski","year":"2008","unstructured":"Nikolovski J, Stamatas GN, Kollias N, Wiegand BC. Barrier function and water-holding and transport properties of infant stratum corneum are different from adult and continue to develop through the first year of life. J Invest Dermatol. 2008;128(7):1728\u201336.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"645_CR43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0190-9622(94)70059-1","volume":"30","author":"BJ Nickoloff","year":"1994","unstructured":"Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol. 1994;30(4):535\u201346.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"645_CR44","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1172\/JCI115884","volume":"90","author":"LC Wood","year":"1992","unstructured":"Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest. 1992;90(2):482\u20137.","journal-title":"J Clin Invest"},{"issue":"2","key":"645_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1055\/s-0032-1333412","volume":"30","author":"AG Cuenca","year":"2013","unstructured":"Cuenca AG, Wynn JL, Moldawer LL, Levy O. Role of innate immunity in neonatal infection. Am J Perinatol. 2013;30(2):105\u201312.","journal-title":"Am J Perinatol"},{"issue":"4","key":"645_CR46","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1203\/PDR.0b013e3181d00b73","volume":"67","author":"V Narendran","year":"2010","unstructured":"Narendran V, Visscher MO, Abril I, Hendrix SW, Hoath SB. Biomarkers of epidermal innate immunity in premature and full-term infants. Pediatr Res. 2010;67(4):382\u20136.","journal-title":"Pediatr Res"},{"issue":"6","key":"645_CR47","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.jid.2016.11.045","volume":"137","author":"RL Gallo","year":"2017","unstructured":"Gallo RL. Human skin is the largest epithelial surface for interaction with microbes. J Invest Dermatol. 2017;137(6):1213\u20134.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"645_CR48","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1365-2133.2011.10659.x","volume":"166","author":"JW Fluhr","year":"2012","unstructured":"Fluhr JW, Darlenski R, Lachmann N, Baudouin C, Msika P, De Belilovsky C, Hachem JP. Infant epidermal skin physiology: adaptation after birth. Br J Dermatol. 2012;166(3):483\u201390.","journal-title":"Br J Dermatol"},{"issue":"7673","key":"645_CR49","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nature24139","volume":"549","author":"CM Powell","year":"2017","unstructured":"Powell CM. Neuroscience: Mum\u2019s bacteria linked to baby\u2019s behaviour. Nature. 2017;549(7673):466\u20137.","journal-title":"Nature"},{"issue":"12","key":"645_CR50","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1038\/sj.jid.5700913","volume":"127","author":"EH Choi","year":"2007","unstructured":"Choi EH, Man MQ, Xu P, Xin S, Liu Z, Crumrine DA, Jiang YJ, Fluhr JW, Feingold KR, Elias PM, et al. Stratum corneum acidification is impaired in moderately aged human and murine skin. J Invest Dermatol. 2007;127(12):2847\u201356.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"645_CR51","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1172\/JCI117919","volume":"95","author":"R Ghadially","year":"1995","unstructured":"Ghadially R, Brown BE, Sequeira-Martin SM, Feingold KR, Elias PM. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest. 1995;95(5):2281\u201390.","journal-title":"J Clin Invest"},{"issue":"5","key":"645_CR52","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/1523-1747.ep12338692","volume":"106","author":"R Ghadially","year":"1996","unstructured":"Ghadially R, Brown BE, Hanley K, Reed JT, Feingold KR, Elias PM. Decreased epidermal lipid synthesis accounts for altered barrier function in aged mice. J Invest Dermatol. 1996;106(5):1064\u20139.","journal-title":"J Invest Dermatol"},{"key":"645_CR53","first-page":"543","volume":"112","author":"J Ye","year":"1999","unstructured":"Ye J, Calhoun C, Feingold K, Elias P, Ghadially R. Age-related changes in the IL-1 gene family and their receptors before and after barrier abrogation. J Invest Dermatol. 1999;112:543.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"645_CR54","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jid.2017.01.007","volume":"137","author":"L Hu","year":"2017","unstructured":"Hu L, Mauro TM, Dang E, Man G, Zhang J, Lee D, Wang G, Feingold KR, Elias PM, Man MQ. Epidermal dysfunction leads to an age-associated increase in levels of serum inflammatory cytokines. J Invest Dermatol. 2017;137(6):1277\u201385.","journal-title":"J Invest Dermatol"},{"issue":"11","key":"645_CR55","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1111\/jdv.15540","volume":"33","author":"L Ye","year":"2019","unstructured":"Ye L, Mauro TM, Dang E, Wang G, Hu LZ, Yu C, Jeong S, Feingold K, Elias PM, Lv CZ, et al. Topical applications of an emollient reduce circulating pro-inflammatory cytokine levels in chronically aged humans: a pilot clinical study. J Eur Acad Dermatol Venereol. 2019;33(11):2197\u2013201.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"645_CR56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/gbb.12256","volume":"15","author":"TM Kazdoba","year":"2016","unstructured":"Kazdoba TM, Leach PT, Crawley JN. Behavioral phenotypes of genetic mouse models of autism. Genes Brain Behav. 2016;15(1):7\u201326.","journal-title":"Genes Brain Behav"},{"issue":"Pt A","key":"645_CR57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","volume":"299","author":"C Nicolini","year":"2018","unstructured":"Nicolini C, Fahnestock M. The valproic acid-induced rodent model of autism. Exp Neurol. 2018;299(Pt A):217\u201327.","journal-title":"Exp Neurol"},{"key":"645_CR58","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3389\/fncel.2018.00422","volume":"12","author":"HY Kuo","year":"2018","unstructured":"Kuo HY, Liu FC. Molecular pathology and pharmacological treatment of autism spectrum disorder-like phenotypes using rodent models. Front Cell Neurosci. 2018;12:422.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"645_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1017\/S1461145711001714","volume":"16","author":"S Kataoka","year":"2013","unstructured":"Kataoka S, Takuma K, Hara Y, Maeda Y, Ago Y, Matsuda T. Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Int J Neuropsychopharmacol. 2013;16(1):91\u2013103.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"645_CR60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/00015559850135788","volume":"78","author":"A Di Nardo","year":"1998","unstructured":"Di Nardo A, Wertz P, Giannetti A, Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol. 1998;78(1):27\u201330.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"645_CR61","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/jid.2013.440","volume":"134","author":"KR Feingold","year":"2014","unstructured":"Feingold KR. The adverse effect of IFN gamma on stratum corneum structure and function in psoriasis and atopic dermatitis. J Invest Dermatol. 2014;134(3):597\u2013600.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"645_CR62","doi-asserted-by":"publisher","first-page":"e98006","DOI":"10.1172\/jci.insight.98006","volume":"3","author":"E Berdyshev","year":"2018","unstructured":"Berdyshev E, Goleva E, Bronova I, Dyjack N, Rios C, Jung J, Taylor P, Jeong M, Hall CF, Richers BN, et al. Lipid abnormalities in atopic skin are driven by type 2 cytokines. JCI Insight. 2018;3(4):e98006.","journal-title":"JCI Insight"},{"issue":"12","key":"645_CR63","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1194\/jlr.P030338","volume":"53","author":"M Janssens","year":"2012","unstructured":"Janssens M, van Smeden J, Gooris GS, Bras W, Portale G, Caspers PJ, Vreeken RJ, Hankemeier T, Kezic S, Wolterbeek R, et al. Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J Lipid Res. 2012;53(12):2755\u201366.","journal-title":"J Lipid Res"},{"issue":"1","key":"645_CR64","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.jid.5701011","volume":"128","author":"MQ Man","year":"2008","unstructured":"Man MQ, Hatano Y, Lee SH, Man M, Chang S, Feingold KR, Leung DY, Holleran W, Uchida Y, Elias PM. Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol. 2008;128(1):79\u201386.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"645_CR65","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jaci.2009.06.046","volume":"124","author":"TC Scharschmidt","year":"2009","unstructured":"Scharschmidt TC, Man MQ, Hatano Y, Crumrine D, Gunathilake R, Sundberg JP, Silva KA, Mauro TM, Hupe M, Cho S, et al. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol. 2009;124(3):496\u2013506.","journal-title":"J Allergy Clin Immunol"},{"issue":"25","key":"645_CR66","doi-asserted-by":"publisher","first-page":"18381","DOI":"10.1074\/jbc.M113.478420","volume":"288","author":"ML Allende","year":"2013","unstructured":"Allende ML, Sipe LM, Tuymetova G, Wilson-Henjum KL, Chen W, Proia RL. Sphingosine-1-phosphate phosphatase 1 regulates keratinocyte differentiation and epidermal homeostasis. J Biol Chem. 2013;288(25):18381\u201391.","journal-title":"J Biol Chem"},{"key":"645_CR67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.brainres.2013.06.024","volume":"1526","author":"MA Edalatmanesh","year":"2013","unstructured":"Edalatmanesh MA, Nikfarjam H, Vafaee F, Moghadas M. Increased hippocampal cell density and enhanced spatial memory in the valproic acid rat model of autism. Brain Res. 2013;1526:15\u201325.","journal-title":"Brain Res"},{"key":"645_CR68","doi-asserted-by":"publisher","first-page":"711","DOI":"10.12688\/f1000research.14969.1","volume":"7","author":"SO Nolan","year":"2018","unstructured":"Nolan SO, Lugo JN. Reversal learning paradigm reveals deficits in cognitive flexibility in the Fmr1 knockout male mouse. F1000Res. 2018;7:711.","journal-title":"F1000Res"},{"issue":"39","key":"645_CR69","doi-asserted-by":"publisher","first-page":"34121","DOI":"10.1074\/jbc.M111.250431","volume":"286","author":"K Park","year":"2011","unstructured":"Park K, Elias PM, Oda Y, Mackenzie D, Mauro T, Holleran WM, Uchida Y. Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway. J Biol Chem. 2011;286(39):34121\u201330.","journal-title":"J Biol Chem"},{"issue":"10","key":"645_CR70","doi-asserted-by":"publisher","first-page":"E1334","DOI":"10.1073\/pnas.1504555113","volume":"113","author":"K Park","year":"2016","unstructured":"Park K, Ikushiro H, Seo HS, Shin KO, Kim YI, Kim JY, Lee YM, Yano T, Holleran WM, Elias P, et al. ER stress stimulates production of the key antimicrobial peptide, cathelicidin, by forming a previously unidentified intracellular S1P signaling complex. Proc Natl Acad Sci USA. 2016;113(10):E1334\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"645_CR71","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1089\/jmf.2018.4246","volume":"21","author":"KO Shin","year":"2018","unstructured":"Shin KO, Choe SJ, Uchida Y, Kim I, Jeong Y, Park K. Ginsenoside Rb1 enhances keratinocyte migration by a sphingosine-1-phosphate-dependent mechanism. J Med Food. 2018;21(11):1129\u201336.","journal-title":"J Med Food"},{"issue":"3","key":"645_CR72","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jid.2018.08.032","volume":"139","author":"SP Hong","year":"2019","unstructured":"Hong SP, Seo HS, Shin KO, Park K, Park BC, Kim MH, Park M, Kim CD, Seo SJ. Adiponectin enhances human keratinocyte lipid synthesis via SIRT1 and nuclear hormone receptor signaling. J Invest Dermatol. 2019;139(3):573\u201382.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"645_CR73","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.ajpath.2018.02.008","volume":"188","author":"EA Mauldin","year":"2018","unstructured":"Mauldin EA, Crumrine D, Casal ML, Jeong S, Opalka L, Vavrova K, Uchida Y, Park K, Craiglow B, Choate KA, et al. Cellular and metabolic basis for the ichthyotic phenotype in NIPAL4 (Ichthyin)-deficient canines. Am J Pathol. 2018;188(6):1419\u201329.","journal-title":"Am J Pathol"},{"issue":"4","key":"645_CR74","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.0022-202X.2005.23651.x","volume":"124","author":"Y Hatano","year":"2005","unstructured":"Hatano Y, Terashi H, Arakawa S, Katagiri K. Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis. J Invest Dermatol. 2005;124(4):786\u201392.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"645_CR75","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/jid.2013.364","volume":"134","author":"C Tawada","year":"2014","unstructured":"Tawada C, Kanoh H, Nakamura M, Mizutani Y, Fujisawa T, Banno Y, Seishima M. Interferon-gamma decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis. J Invest Dermatol. 2014;134(3):712\u20138.","journal-title":"J Invest Dermatol"},{"issue":"14","key":"645_CR76","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/NEJMra074081","volume":"358","author":"T Bieber","year":"2008","unstructured":"Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14):1483\u201394.","journal-title":"N Engl J Med"},{"issue":"9352","key":"645_CR77","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0140-6736(03)12193-9","volume":"361","author":"DY Leung","year":"2003","unstructured":"Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361(9352):151\u201360.","journal-title":"Lancet"},{"issue":"10","key":"645_CR78","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1038\/jid.2011.175","volume":"131","author":"M Janssens","year":"2011","unstructured":"Janssens M, van Smeden J, Gooris GS, Bras W, Portale G, Caspers PJ, Vreeken RJ, Kezic S, Lavrijsen AP, Bouwstra JA. Lamellar lipid organization and ceramide composition in the stratum corneum of patients with atopic eczema. J Invest Dermatol. 2011;131(10):2136\u20138.","journal-title":"J Invest Dermatol"},{"key":"645_CR79","unstructured":"Report on the results of fun life program, a project for promoting the health of persons with autism and their families. https:\/\/autismkorea.kr\/."},{"key":"645_CR80","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ebcr.2017.06.003","volume":"8","author":"XT Wu","year":"2017","unstructured":"Wu XT, Hong PW, Suolang DJ, Zhou D, Stefan H. Drug-induced hypersensitivity syndrome caused by valproic acid as a monotherapy for epilepsy: first case report in Asian population. Epilepsy Behav Case Rep. 2017;8:108\u201310.","journal-title":"Epilepsy Behav Case Rep"},{"issue":"9","key":"645_CR81","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/ijd.14411","volume":"58","author":"M Rashid","year":"2019","unstructured":"Rashid M, Kashyap A, Undela K. Valproic acid and Stevens\u2013Johnson syndrome: a systematic review of descriptive studies. Int J Dermatol. 2019;58(9):1014\u201322.","journal-title":"Int J Dermatol"},{"key":"645_CR82","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12948-017-0072-5","volume":"15","author":"F De Luca","year":"2017","unstructured":"De Luca F, Losappio LM, Mirone C, Schroeder JW, Citterio A, Aversano MG, Scibilia J, Pastorello EA. Tolerated drugs in subjects with severe cutaneous adverse reactions (SCARs) induced by anticonvulsants and review of the literature. Clin Mol Allergy. 2017;15:16.","journal-title":"Clin Mol Allergy"},{"issue":"2","key":"645_CR83","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.pedneo.2016.01.009","volume":"58","author":"H Mutlu-Albayrak","year":"2017","unstructured":"Mutlu-Albayrak H, Bulut C, Caksen H. Fetal valproate syndrome. Pediatr Neonatol. 2017;58(2):158\u201364.","journal-title":"Pediatr Neonatol"},{"issue":"4","key":"645_CR84","doi-asserted-by":"publisher","first-page":"285","DOI":"10.5607\/en.2015.24.4.285","volume":"24","author":"DF Mabunga","year":"2015","unstructured":"Mabunga DF, Gonzales EL, Kim JW, Kim KC, Shin CY. Exploring the validity of valproic acid animal model of autism. Exp Neurobiol. 2015;24(4):285\u2013300.","journal-title":"Exp Neurobiol"},{"key":"645_CR85","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3030268","author":"H Kanoh","year":"2019","unstructured":"Kanoh H, Ishitsuka A, Fujine E, Matsuhaba S, Nakamura M, Ito H, Inagaki N, Banno Y, Seishima M. IFN-gamma reduces epidermal barrier function by affecting fatty acid composition of ceramide in a mouse atopic dermatitis model. J Immunol Res. 2019. https:\/\/doi.org\/10.1155\/2019\/3030268.","journal-title":"J Immunol Res"},{"issue":"1","key":"645_CR86","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.expneurol.2004.01.009","volume":"187","author":"G Wong","year":"2004","unstructured":"Wong G, Goldshmit Y, Turnley AM. Interferon-gamma but not TNF alpha promotes neuronal differentiation and neurite outgrowth of murine adult neural stem cells. Exp Neurol. 2004;187(1):171\u20137.","journal-title":"Exp Neurol"},{"issue":"2","key":"645_CR87","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/0012-1606(91)90433-4","volume":"144","author":"ME Barish","year":"1991","unstructured":"Barish ME, Mansdorf NB, Raissdana SS. Gamma-interferon promotes differentiation of cultured cortical and hippocampal neurons. Dev Biol. 1991;144(2):412\u201323.","journal-title":"Dev Biol"},{"issue":"Pt 3","key":"645_CR88","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1042\/BJ20040320","volume":"381","author":"R Schneiter","year":"2004","unstructured":"Schneiter R, Brugger B, Amann CM, Prestwich GD, Epand RF, Zellnig G, Wieland FT, Epand RM. Identification and biophysical characterization of a very-long-chain-fatty-acid-substituted phosphatidylinositol in yeast subcellular membranes. Biochem J. 2004;381(Pt 3):941\u20139.","journal-title":"Biochem J"},{"issue":"5","key":"645_CR89","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/jb\/mvs105","volume":"152","author":"A Kihara","year":"2012","unstructured":"Kihara A. Very long-chain fatty acids: elongation, physiology and related disorders. J Biochem. 2012;152(5):387\u201395.","journal-title":"J Biochem"},{"issue":"10","key":"645_CR90","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.tcb.2011.06.004","volume":"21","author":"S Aggarwal","year":"2011","unstructured":"Aggarwal S, Yurlova L, Simons M. Central nervous system myelin: structure, synthesis and assembly. Trends Cell Biol. 2011;21(10):585\u201393.","journal-title":"Trends Cell Biol"},{"issue":"6","key":"645_CR91","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1176\/appi.ajp.2011.11091447","volume":"169","author":"JJ Wolff","year":"2012","unstructured":"Wolff JJ, Gu H, Gerig G, Elison JT, Styner M, Gouttard S, Botteron KN, Dager SR, Dawson G, Estes AM, et al. Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. Am J Psychiatry. 2012;169(6):589\u2013600.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"645_CR92","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1124\/jpet.117.240564","volume":"361","author":"AB Patel","year":"2017","unstructured":"Patel AB, Theoharides TC. Methoxyluteolin inhibits neuropeptide-stimulated proinflammatory mediator release via mTOR activation from human mast cells. J Pharmacol Exp Ther. 2017;361(3):462\u201371.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"645_CR93","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/0394632017707610","volume":"30","author":"TC Theoharides","year":"2017","unstructured":"Theoharides TC, Stewart JM, Tsilioni I. Tolerability and benefit of a tetramethoxyluteolin-containing skin lotion. Int J Immunopathol Pharmacol. 2017;30(2):146\u201351.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"45","key":"645_CR94","doi-asserted-by":"publisher","first-page":"E7049","DOI":"10.1073\/pnas.1604992113","volume":"113","author":"AB Patel","year":"2016","unstructured":"Patel AB, Tsilioni I, Leeman SE, Theoharides TC. Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism. Proc Natl Acad Sci USA. 2016;113(45):E7049\u201358.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-021-00645-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12868-021-00645-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-021-00645-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T04:06:39Z","timestamp":1624334799000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/s12868-021-00645-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["645"],"URL":"https:\/\/doi.org\/10.1186\/s12868-021-00645-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-36694\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-36694\/v1","asserted-by":"object"}]},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"assertion":[{"value":"23 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were subjected to approval by the Ethical Committee on Animal Experiments, Hallym University, Korea (permit number: Hallym-2018-84) and performed accordingly.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not available.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. B.D. Park is CEO of SphingoBrain Inc., San Francisco, CA, which has a pending patent application (US15981669) related to the diagnosis and amelioration of atopic dermatitis-associated autism spectrum disorders; Dr. Elias is a non-paid consultant to SphingoBrain. None of the authors have any non-financial conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}